Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07193823

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Sexual Dysfunction Prevalence and Its Relationship With Various Factors in Women With Multiple Sclerosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Ege University · Academic / Other
Sex
Female
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction. For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Conditions

Timeline

Start date
2024-07-16
Primary completion
2025-10-01
Completion
2025-11-01
First posted
2025-09-26
Last updated
2025-09-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07193823. Inclusion in this directory is not an endorsement.